Frontline Diagnostic Tool for Disease Management in Urinalysis

Urinalysis testing is used as the frontline diagnostic tool in the diagnosis of various metabolic abnormalities and UTIs. Urinalysis is also used as a disease management tool for the treatment of chronic diseases such as diabetes, chronic kidney disease (CKD), and urinary bladder cancer. Rising kidney diseases owing to change in food consumption habits accompanied by growing concerns from geriatric population are among major industry drivers.

As urinalysis plays an integral role in the diagnosis of such diseases, the urinalysis market is expected to grow significantly in the near future. The growing prevalence of these target diseases and the introduction of technologically advanced, rapid, noninvasive, and user-friendly tools for urinalysis are estimated to be the major growth drivers of this market. The Asia-Pacific urinalysis market share is expected to witness growth of over 7 percent CAGR up to 2023, mainly due to demand across India and China. Increase in advanced urine analyzers adoption coupled with large number of untapped population is forecast to present attractive growth opportunities.

The consumables segment accounts for the largest share of the global market. Key reasons to influence demand of consumables segment leading to global revenue are increasing test strips and reagents usage due to self-awareness. Dipstick, disposables, and reagents are the major consumables in the industry.

Clinical laboratories are the dominant segment and account for around 35 percent of the global share. Growing concerns pertaining to hygiene and cleanliness accompanied by increase in number of hospitals and healthcare centers should positively drive demand.

The disease diagnosis application segment is projected to witness the highest CAGR in the coming years due to factors such as increasing research for the development of new urinalysis tests for better, early diagnosis of chronic diseases, and increasing incidences of chronic diseases.